Understanding why cancer survivors relapse to tobacco use
Examining Tobacco Use Relapse among Cancer Survivors
This study is looking at why cancer survivors who have quit smoking might start again, focusing on their feelings and social situations, and it’s designed for those who have recently stopped or are at risk of going back to tobacco use, to help improve support and prevention strategies for them.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10826836 on NIH RePORTER |
What this research studies
This research investigates the reasons behind tobacco use relapse among cancer survivors, focusing on both personal and social factors. By utilizing innovative survey methods, including ecological momentary assessment, the study aims to capture real-time data on the emotions and social influences that may lead to relapse. Participants will be cancer survivors who have recently quit or are at risk of relapsing, providing valuable insights into their experiences and challenges. The goal is to enhance cancer prevention strategies and support for survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors who have recently quit using tobacco or are at risk of relapse.
Not a fit: Patients who have never used tobacco or those who are not cancer survivors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved interventions that help cancer survivors maintain tobacco abstinence and reduce negative health outcomes.
How similar studies have performed: Previous research has shown that understanding the social and emotional factors influencing tobacco use can lead to effective interventions, indicating that this approach has potential for success.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Fugate-Laus, Kendall — Virginia Commonwealth University
- Study coordinator: Fugate-Laus, Kendall
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.